Cell and gene therapy reimbursement rate
Percentage of cell and gene therapies that are reimbursed in a given country or region.
Unit Percent Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Cell and gene therapy reimbursement rate
European Union, as of 1 Apr 2023
Every record
All records
2 records · 1 region · 2023
| Period | Value | Source | Type |
|---|---|---|---|
| European Union 2 records | |||
| April 2023 | 42% | IQVIA · 30 Apr 2023 | actual |
| as of 1 Apr 2023 | 42% | IQVIA · 1 Apr 2023 | actual |
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios | IQVIA | — | 2 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Cell and gene therapy reimbursement rate. Retrieved from https://statorigin.org/indicators/cell-and-gene-therapy-reimbursement-rate